Bank of America
BLPH

Bank of America’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Bank of America’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-43
Closed – – 8830
2022
Q1 		$0 Sell
43
-47
-52% -$112 ﹤0.01% 9167
2021
Q4 		$0 Buy
90
+16
+22% +$53 ﹤0.01% 9071
2021
Q3 		$0 Sell
74
-666
-90% -$2.77K ﹤0.01% 8701
2021
Q2 		$4K Sell
740
-11,259
-94% -$50.5K ﹤0.01% 7483
2021
Q1 		$63K Buy
11,999
+5,055
+73% +$35.2K ﹤0.01% 6559
2020
Q4 		$46K Buy
6,944
+441
+7% +$3.61K ﹤0.01% 6362
2020
Q3 		$66K Buy
6,503
+2
+0% +$24 ﹤0.01% 5895
2020
Q2 		$82K Buy
6,501
+6,488
+49,908% +$90.8K ﹤0.01% 5775
2020
Q1 		$0 Buy
+13
New +$87 ﹤0.01% 7552
2019
Q4 		– Sell
-567
Closed -$4K – 7636
2019
Q3 		$4K Buy
567
+403
+246% +$3.67K ﹤0.01% 6916
2019
Q2 		$1K Buy
+164
New +$1.57K ﹤0.01% 7120
2018
Q4 		– Sell
-214
Closed -$3K – 7565
2018
Q3 		$3K Buy
+214
New +$5.08K ﹤0.01% 6992
2018
Q2 		– Sell
-74
Closed -$2K – 7466
2018
Q1 		$2K Sell
74
-990
-93% -$31.5K ﹤0.01% 6928
2017
Q4 		$41K Buy
+1,064
New +$27.9K ﹤0.01% 6165
2016
Q4 		– Hold
0
– – – 7489
2016
Q3 		– Hold
0
– – – 7496
2016
Q2 		– Sell
-80
Closed -$2.19K – 7536
2016
Q1 		$3K Hold
80
– – ﹤0.01% 6727
2015
Q4 		$4K Hold
80
– – ﹤0.01% 6976
2015
Q3 		$6K Hold
80
– – ﹤0.01% 6724
2015
Q2 		$10K Buy
+80
New +$10.9K ﹤0.01% 6603

Other funds holding BLPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Bank of America's BLPH Position: Q2 2022 in Review

Bank of America sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q2 2022, closing a stake of 43 shares.

Bank of America first reported a position in BLPH in Q2 2015 and held it in 18 quarters. The position peaked at $82K in Q2 2020. 19 funds tracked by Wall St. Rank hold BLPH as of Q2 2022.

  • Bank of America reported no remaining Bellerophon Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
  • Bank of America sold 43 Bellerophon Therapeutics, Inc. shares in Q2 2022.
  • Bank of America first reported a position in Bellerophon Therapeutics, Inc. in Q2 2015 and held it in 18 quarters.
  • Bank of America's Bellerophon Therapeutics, Inc. position peaked at $82K in Q2 2020.
  • 19 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q2 2022.

Based on Bank of America's 13F filing for Q2 2022, filed 12 Aug 2022.